Unfinished Labeling Business: Pregnancy, In Vitro Data, Containers

FDA's final labeling rule defers revisions to labeling issues such as the content and format of the Pregnancy subsection, inclusion of in vitro data and the requirements for container labels

More from Archive

More from Pink Sheet